BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 19509099)

  • 1. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline.
    Hembree WC; Cohen-Kettenis P; Delemarre-van de Waal HA; Gooren LJ; Meyer WJ; Spack NP; Tangpricha V; Montori VM;
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3132-54. PubMed ID: 19509099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
    Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
    J Clin Endocrinol Metab; 2017 Nov; 102(11):3869-3903. PubMed ID: 28945902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine treatment of transsexual persons: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective.
    Meriggiola MC; Jannini EA; Lenzi A; Maggi M; Manieri C
    Eur J Endocrinol; 2010 May; 162(5):831-3. PubMed ID: 20150325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
    Smith KP; Madison CM; Milne NM
    Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adolescents with gender identity disorder: reconsideration of the age limits for endocrine treatment and surgery].
    Nakatsuka M
    Seishin Shinkeigaku Zasshi; 2012; 114(6):647-53. PubMed ID: 22844815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Puberty-delaying hormone therapy in adolescents with gender identity disorder].
    Nakatsuka M
    Seishin Shinkeigaku Zasshi; 2013; 115(3):316-22. PubMed ID: 23691819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of gender identity disorder in childhood and adolescence: guidelines, barriers and areas of controversy.
    Shumer DE; Spack NP
    Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):69-73. PubMed ID: 23221495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents.
    Schagen SE; Cohen-Kettenis PT; Delemarre-van de Waal HA; Hannema SE
    J Sex Med; 2016 Jul; 13(7):1125-32. PubMed ID: 27318023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for pubertal suspension and gender reassignment for transgender adolescents.
    Hembree WC
    Child Adolesc Psychiatr Clin N Am; 2011 Oct; 20(4):725-32. PubMed ID: 22051008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice. Care of transsexual persons.
    Gooren LJ
    N Engl J Med; 2011 Mar; 364(13):1251-7. PubMed ID: 21449788
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of juvenile gender dysphoria.
    Hembree WC
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):559-64. PubMed ID: 24468758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term evaluation of cross-sex hormone treatment in transsexual persons.
    Wierckx K; Mueller S; Weyers S; Van Caenegem E; Roef G; Heylens G; T'Sjoen G
    J Sex Med; 2012 Oct; 9(10):2641-51. PubMed ID: 22906135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How young is too young: ethical concerns in genital surgery of the transgender MTF adolescent.
    Milrod C
    J Sex Med; 2014 Feb; 11(2):338-46. PubMed ID: 24238576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjectures concerning cross-sex hormone treatment of aging transsexual persons.
    Gooren L; Lips P
    J Sex Med; 2014 Aug; 11(8):2012-9. PubMed ID: 24775178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine treatment of transsexual persons: extensive personal experience.
    Leinung MC; Urizar MF; Patel N; Sood SC
    Endocr Pract; 2013; 19(4):644-50. PubMed ID: 23512380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRHa ('Puberty Blockers') and Cross Sex Hormones for Children and Adolescents: Informed Consent, Personhood and Freedom of Expression.
    Pilgrim D; Entwistle K
    New Bioeth; 2020 Sep; 26(3):224-237. PubMed ID: 32715988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis and care of transsexual children and adolescents: a pediatric endocrinologists' perspective.
    Houk CP; Lee PA
    J Pediatr Endocrinol Metab; 2006 Feb; 19(2):103-9. PubMed ID: 16562581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Medical Treatment of Children and Adolescents With Gender Dysphoria: An Empirical Ethical Study.
    Vrouenraets LJ; Fredriks AM; Hannema SE; Cohen-Kettenis PT; de Vries MC
    J Adolesc Health; 2015 Oct; 57(4):367-73. PubMed ID: 26119518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.
    Rowniak S; Bolt L; Sharifi C
    JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1826-1854. PubMed ID: 31021971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects.
    Moore E; Wisniewski A; Dobs A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3467-73. PubMed ID: 12915619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.